+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Alcoholic liver cirrhosis. Screening for hepatocellular carcinoma in liver cirrhosis



Alcoholic liver cirrhosis. Screening for hepatocellular carcinoma in liver cirrhosis



Presse Medicale 30(23): 1164-1169



HIGH INCIDENCE: Because of the high incidence of hepatocellular carcinoma (HCC) in patients with cirrhosis (3 to 5% per year) and the fact that curative treatment is currently available only for small sized tumors careful screening is warranted in this high risk population. Earlier screening attempts produced disappointing results in terms of cure and survival, particularly in Europe. Progress in ultrasonography, a better understanding of the risk of developing HCC, and most importantly the advent of local percutaneous treatments have greatly affected the data which should be reexamined. SCREENING METHODS: Patients with cirrhosis, particularly alcoholic or viral cirrhosis, should undergo regular ultrasound examinations, every six months for most screening protocols although the best timing remains unknown. Assay of serum alpha-fetoprotein is of limited use due to its low sensitivity and specificity. Diagnosis of HCC is basically based on helicoidal computed tomography and/or magnetic resonance imaging findings, with or without pathological proof (ultrasound-guided biopsy) that may be difficult to obtain. A probabilistic diagnosis is therefore retained if necessary, based on the presence of risk factors and arterial hypervascularization of a liver nodule. EARLY TREATMENT: With ultrasound screening, the diagnosis of HCC can generally be established early, when curative transplantation, resection or local percutaneous destruction are still feasible. The percutaneous methods use chemical or physical agents to destroy the tumor. There are few contraindications so curative treatment can be proposed for large number of patients. Large-scale prospective studies will be completed in the upcoming years and are expected to provide evidence validating the principle of screening and early treatment.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 045198118

Download citation: RISBibTeXText

PMID: 11505839


Related references

Clinicopathological studies and operative results of hepatocellular carcinoma with liver cirrhosis, comparing HB-associated cirrhosis to alcoholic and post-transfusion cirrhosis. Gastroenterologia Japonica 25(1): 54-60, 1990

Hepatocellular carcinoma in nonalcoholic fatty liver cirrhosis and alcoholic cirrhosis: risk factor analysis in liver transplant recipients. European Journal of Gastroenterology and Hepatology 24(7): 840-848, 2012

A comparative study of liver cell regenerative activity between primary biliary cirrhosis, alcoholic cirrhosis, hepatitic cirrhosis, and hepatocellular carcinoma using figure analysis. Tropical Medicine 37(1): 13-20, 1995

Regenerative pattern of liver cells in primary biliary cirrhosis, alcoholic cirrhosis, posthepatitic cirrhosis (HBV-related) and hepatocellular carcinoma: Comparative analysis by computerized morphometry. Pathology International 46(4): 267-273, 1996

A case of hepatocellular carcinoma developed in a patient with alcoholic liver cirrhosis with primary biliary cirrhosis. Nihon Shokakibyo Gakkai Zasshi 97(1): 54-59, 2000

Plasma osteopontin is a biomarker for the severity of alcoholic liver cirrhosis, not for hepatocellular carcinoma screening. Bmc Gastroenterology 15: 73, 2015

Liver cirrhosis.An advance on diagnosis and treatment.4.Clinical feature of alcoholic cirrhosis.The comparison with viral liver cirrhosis. Nihon Naika Gakkai Zasshi 80(10): 1587-1591, 1991

Alcoholic liver cirrhosis. Treatment of hepatocellular carcinoma. Presse Medicale 30(23): 1170-1177, 2001

Coronary Artery Disease in Liver Cirrhosis: A Comparison Between Nash-Related Cirrhosis, Alcoholic Cirrhosis and Cirrhosis Due to Other Etiologies. Gastroenterology 136(5): A-796, 2009

Metabolomic analysis of human cirrhosis, hepatocellular carcinoma, non-alcoholic fatty liver disease and non-alcoholic steatohepatitis diseases. Gastroenterology and Hepatology from Bed to Bench 9(3): 158-173, 2016

Diabetes Mellitus Predicts Occurrence of Cirrhosis and Hepatocellular Cancer in Alcoholic Liver and Non-alcoholic Fatty Liver Diseases. Journal of Clinical and Translational Hepatology 3(1): 9, 2015

Association between the HFE C282Y, H63D Polymorphisms and the Risks of Non-Alcoholic Fatty Liver Disease, Liver Cirrhosis and Hepatocellular Carcinoma: An Updated Systematic Review and Meta-Analysis of 5,758 Cases and 14,741 Controls. Plos one 11(9): E0163423, 2016

Liver transplantation for alcoholic liver disease: Survival of patients transplanted with alcoholic hepatitis plus cirrhosis as compared with those with cirrhosis alone. Alcoholism Clinical and Experimental Research 17(5): 1102-1106, 1993

Genetic instability and mismatch repair genes in liver biopsies from patients with advanced liver cirrhosis and from patients with hepatocellular carcinoma developed in previous cirrhosis. Journal of Hepatology 28(Suppl. 1): 81, 1998

Image cytometry of hepatocellular carcinoma: comparison with alcoholic cirrhosis and normal liver. Analytical Cellular Pathology 5(2): 103-111, 1993